Profilo
Danilo Piroli currently works at Chiesi Ltd., as Director from 1999.
Mr. Piroli also formerly worked at Zymenex A, as Director, CHIESI Farmaceutici SpA, as Director-Corporate Finance, and Chiesi SAS, as Director.
Posizioni attive di Danilo Piroli
| Società | Posizione | Inizio |
|---|---|---|
Chiesi Ltd.
Chiesi Ltd. Pharmaceuticals: MajorHealth Technology Develops, markets and supplies therapeutic products | Direttore/Membro del Consiglio | 03/02/2011 |
Precedenti posizioni note di Danilo Piroli
| Società | Posizione | Fine |
|---|---|---|
Chiesi SAS
Chiesi SAS Pharmaceuticals: GenericHealth Technology Wholesales and distributes pharmaceutical products | Direttore/Membro del Consiglio | - |
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Engages in the research and development of therapeutics for life threatening diseases | Direttore/Membro del Consiglio | - |
CHIESI Farmaceutici SpA
CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and markets respiratory health, rare diseases and specialty care products | Direttore Finanziario/CFO | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
CHIESI Farmaceutici SpA
CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and markets respiratory health, rare diseases and specialty care products | Health Technology |
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Engages in the research and development of therapeutics for life threatening diseases | Health Technology |
Chiesi SAS
Chiesi SAS Pharmaceuticals: GenericHealth Technology Wholesales and distributes pharmaceutical products | Health Technology |
Chiesi Ltd.
Chiesi Ltd. Pharmaceuticals: MajorHealth Technology Develops, markets and supplies therapeutic products | Health Technology |
















